[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"risk-of-premature-ovarian-failure\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:risk-of-premature-ovarian-failure":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100175494",false,"NCT01558544","Cryopreservation of Ovarian Tissue","Cryopreservation of Ovarian Tissue for Potential In Vitro Maturation or Autologous Transplantation","Inclusion Criteria:\n\n* Females 0-45 years of age who are premenopausal\n* Treatment plan that will likely result in premature menopause or premature ovarian failure\n* This includes patients receiving:\n* Cancer treatment with abdominal pelvic irradiation and\u002For high dose chemotherapy\n* Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients\n* Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos.\n* Previous treatment for cancer is acceptable if patient still has ovarian function\n* Patient is medically stable enough to undergo surgery (cleared for anesthesia)\n\nExclusion Criteria:\n\n* Patients not meeting the above criteria\n* Patients who have not received medical clearance from their physicians to undergo surgery\n* Patients already experiencing menopause.","FEMALE","45 Years",{"count":18,"type":19},300,"ESTIMATED","INTERVENTIONAL",[22],"NA","The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.",[25,26,27],"Cancer","Risk of Premature Ovarian Failure","Fertility Preservation",[29,30,31,32],"Ovarian tissue cryopreservation","Ovarian tissue transplantation","Fertility preservation","Risk of premature ovarian failure","RECRUITING","2025-12-09",{"date":36,"type":37},"2025-12-10","ACTUAL",{"date":39,"type":37},"1997-04",{"date":41,"type":19},"2029-10-31",{"name":43,"class":44},"Weill Medical College of Cornell University","OTHER",""]